Safety of Bariatric Surgery During the Opening Phase After the First Wave of the COVID-19 Pandemic: Experience at an Academic Center

Simple item page
dc.contributor.authorCrovari, Fernando
dc.contributor.authorInzunza, Martin
dc.contributor.authorIrarrazaval, Maria J.
dc.contributor.authorRomero, Cecilia
dc.contributor.authorAchurra, Pablo
dc.contributor.authorQuezada, Nicolas
dc.contributor.authorGabrielli, Mauricio
dc.contributor.authorMunoz, Rodrigo
dc.date.accessioned2025-01-20T22:09:13Z
dc.date.available2025-01-20T22:09:13Z
dc.date.issued2021
dc.description.abstractIntroduction Increased morbimortality in patients with COVID-19 infection who had undergone surgery has raised concerns about bariatric surgery safety during the current COVID-19 pandemic. Currently, there is scarce literature on safety outcomes after bariatric surgery during the COVID-19 pandemic.
dc.description.abstractObjectives To determine the risk of symptomatic COVID-19 infection and associated complications during the first 30 days after bariatric surgery.
dc.description.abstractMaterials and Methods Prospective observational cohort study including all patients who consecutively underwent primary bariatric surgery between August and December 2020.
dc.description.abstractResults A total of 189 patients were included. Median age and BMI were 36 (17-70) years and 38 (35-41) kg/m(2), respectively. Forty percent of patients were women (n = 76), 59.3% (n = 112) underwent sleeve gastrectomy ( SG), and 40.7% (n = 77) underwent Roux-en-Y gastric bypass (RYGB). All surgeries were performed laparoscopically. The median length of postoperative stay was 2 (0-5) days. Postoperative COVID-19 infection was detected in two patients (1.1%): one patient was readmitted without the need of intermediate or ICU care, and the other was managed as an outpatient. Major complications occurred in three patients (1.6%); none of them was COVID-19 related. Two patients required an unplanned reoperation. No patient required intermediate or ICU care, no severe COVID-19 complications were observed, and no mortality was reported.
dc.description.abstractConclusion Bariatric surgery can be safely performed during the ongoing pandemic, albeit a low risk of COVID- 19 symptomatic infection. Rigorous perioperative COVID-19 institutional protocols are required to perform bariatric surgery safely during the current pandemic.
dc.fuente.origenWOS
dc.identifier.doi10.1007/s11695-021-05695-1
dc.identifier.eissn1708-0428
dc.identifier.issn0960-8923
dc.identifier.urihttps://doi.org/10.1007/s11695-021-05695-1
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/94324
dc.identifier.wosidWOS:000692437300001
dc.issue.numero12
dc.language.isoen
dc.pagina.final5382
dc.pagina.inicio5376
dc.revistaObesity surgery
dc.rightsacceso restringido
dc.subjectCOVID-19
dc.subjectBariatric surgery
dc.subjectRoux-en-Y gastric bypass
dc.subjectSleeve gastrectomy
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleSafety of Bariatric Surgery During the Opening Phase After the First Wave of the COVID-19 Pandemic: Experience at an Academic Center
dc.typeartículo
dc.volumen31
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files
Collections
Artículos de revistas